Business / Finance

RSS

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Halyard Health, Inc. today reported year-end 2014 results and provided its 2015 outlook and related key planning assumptions.

4 Mar 2015

Lexicon updates drug development progress, reports 2014 financial results

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2014.

4 Mar 2015

Grifols, Alkahest sign definitive agreements

Grifols, a global healthcare company and leading producer of plasma therapies, and Alkahest, a Redwood City, California based, privately held biopharmaceutical company founded upon the pioneering work of Dr. Tony Wyss-Coray and other leading scientists at Stanford University, today announced that they have signed definitive agreements whereby Grifols will make a major equity investment in Alkahest, and the companies will work together to develop novel plasma-based products for the treatment of cognitive decline in aging and disorders of the central nervous system (CNS), including Alzheimer's.

4 Mar 2015

NHS savings plan led to cuts in some ‘ineffective’ treatments

The drive to reduce NHS spending led to a drop in some treatments considered ‘low-value’, according to new research.

4 Mar 2015

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

4 Mar 2015

Regenicin receives final payment to conclude Asset Purchase Agreement with Amarantus

Regenicin, Inc. a biotechnology company specializing in the development of and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs, announced today that it has received the final payment to conclude The Asset Purchase Agreement with Amarantus Bioscience Holdings, Inc.

3 Mar 2015

VWR, New England Biolabs expand distribution agreement

VWR, a leading, independent provider of laboratory products, services and solutions, announced today the expansion of its distribution agreement with New England Biolabs, Inc.

From New England Biolabs 3 Mar 2015

American Biosurgical announces acquisition of MTI

American Biosurgical, LLC a privately owned, custom medical cable manufacturer actively engaged in the design, development and production of innovative medical interconnect technologies for the world's leading medical device companies has announced the acquisition of MTI Corporation, a high precision, low volume custom medical cable manufacturer based in North Carolina.

3 Mar 2015

Chrono Therapeutics gets support to develop SmartStop device for smoking cessation

Chrono Therapeutics, a pioneer in digital drug products, today announced an investment by Rock Health, the leading seed fund in digital health, to support the advancement of Chrono's SmartStop programmable transdermal drug delivery system and real-time behavioral support program for smoking cessation.

3 Mar 2015

Rigel Pharmaceuticals reports net loss of $22.3 million for fourth quarter 2014

Rigel Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2014. For the fourth quarter of 2014, Rigel reported a net loss of $22.3 million, or $0.25 per share, compared to a net loss of $16.9 million, or $0.19 per share, in the fourth quarter of 2013.

3 Mar 2015

SCIEX and Labor Berlin Collaboration to Advance Forensic Testing

SCIEX announced today a research collaboration with Labor Berlin, the largest clinical laboratory in Germany, for the development of a hybrid Quadrupole Time-of-Flight (TOF) MS/MS reference library of relevant forensic chemical compounds

3 Mar 2015

New pocket LED diagnostic sets from Welch Allyn

Exactly 100 years since Welch Allyn invented the world’s first self-illuminating hand-held ophthalmoscope, the company has launched a new Pocket LED set - proof of their continuing ability to keep pushing the boundaries with a winning combination of customer-pleasing quality, reliability and cutting edge technology.

2 Mar 2015

Prime Healthcare acquires two hospitals from subsidiaries of Community Health Systems

Prime Healthcare announced today that it has completed its acquisition of two hospitals from subsidiaries of Community Health Systems: Dallas Regional Medical Center in Mesquite, Texas and Riverview Regional Medical Center in Gadsden, Alabama, as well as related outpatient services.

2 Mar 2015

Endo International’s revenues increase $800 million to 37% in fourth quarter 2014

Endo International plc today reported fourth quarter 2014 revenues of $800 million, an increase of 37 percent compared to fourth quarter 2013 revenues of $585 million, including new product revenue from 2014 strategic M&A transactions.

2 Mar 2015

BioScrip’s total revenue increases $28.2 million to 2.5% in fourth quarter 2014

BioScrip®, Inc. today announced 2014 fourth quarter financial results. Fourth quarter revenue from continuing operations was $253.7 million and the net loss from continuing operations was $61.9 million, or $0.90 per basic and diluted share.

2 Mar 2015

Celimmune licenses anti-IL-15 monoclonal antibody from Amgen

Celimmune LLC, a clinical development-stage immunotherapy company focused on treating and preventing autoimmune diseases, announced today that it has licensed a Phase 2-stage, anti-IL-15 monoclonal antibody (AMG 714) from Amgen.

2 Mar 2015

BioMed Realty recaptures valuable properties in Cambridge innovation district

BioMed Realty Trust, Inc. (NYSE: BMR) today announced it has recaptured approximately 313,000 square feet of space in the most dynamic and valuable life science real estate market in the world through the termination of Vertex Pharmaceuticals' leases on three properties in Cambridge, Massachusetts effective February 28, 2015.

2 Mar 2015

PTI Launches Game-based Learning for the Pharma, Biotech and Medical Device Industries

Pharmaceutical Training International (PTI), the leading supplier of online and public, event-based training courses for the pharma, biotech and medical device sectors, has launched a range of game-based e-learning courses.

From Pharmaceutical Training International 2 Mar 2015

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Mundipharma International Limited’s network of independent associated companies are launching Remsima® (infliximab) this month in Germany, Italy, UK, Netherlands, Belgium and Luxembourg following expiry of the relevant patents and Supplementary Protection Certificates, having secured distribution rights from Celltrion Healthcare Hungary Kft for Remsima in these markets.

1 Mar 2015

Novel financing technique may unlock funding for developing 'orphan' drugs to treat rare diseases

A paper published today, "Financing translation: Analysis of the NCATS rare-diseases portfolio" in Science Translational Medicine, demonstrates the potential of a new financing technique to reduce the risk associated with investing in the treatment of new diseases and potentially unlock new levels of funding for developing so-called "orphan" drugs.

28 Feb 2015

Business / Finance

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Lexicon updates drug development progress, reports 2014 financial results

Grifols, Alkahest sign definitive agreements

NHS savings plan led to cuts in some ‘ineffective’ treatments

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

Regenicin receives final payment to conclude Asset Purchase Agreement with Amarantus

VWR, New England Biolabs expand distribution agreement

American Biosurgical announces acquisition of MTI

Chrono Therapeutics gets support to develop SmartStop device for smoking cessation

Rigel Pharmaceuticals reports net loss of $22.3 million for fourth quarter 2014

SCIEX and Labor Berlin Collaboration to Advance Forensic Testing

New pocket LED diagnostic sets from Welch Allyn

Prime Healthcare acquires two hospitals from subsidiaries of Community Health Systems

Endo International’s revenues increase $800 million to 37% in fourth quarter 2014

BioScrip’s total revenue increases $28.2 million to 2.5% in fourth quarter 2014

Celimmune licenses anti-IL-15 monoclonal antibody from Amgen

BioMed Realty recaptures valuable properties in Cambridge innovation district

PTI Launches Game-based Learning for the Pharma, Biotech and Medical Device Industries

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Novel financing technique may unlock funding for developing 'orphan' drugs to treat rare diseases

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News